Startups
A superior, next generation transgenic mouse platform for the discovery of therapeutic antibodies
Overview
Employees
11-50
Total raised
$12M
Founded date
2009
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 2, 2010 | Ablexis Raises $12M in Series A Financing | Ablexis, LLC, a San Francisco, California-based biotechnology company dedicated to developing an innovative platform for antibody drug discovery, has completed a $12m Series A financing. The round was led by Third Rock Ventures, with partic... |
Reviews 0
FAQ about Ablexis, LLC
When was Ablexis, LLC founded?
Ablexis, LLC was founded in 2009.
How much funding has Ablexis, LLC raised?
Ablexis, LLC has raised $12M in total across 1 funding round.
What has the press written about Ablexis, LLC?
Parsers VC has collected 2 articles mentioning Ablexis, LLC, among them “Ablexis Raises $12M in Series A Financing” (Jun 2, 2010).
Is Ablexis, LLC still active?
Yes, Ablexis, LLC is active; its latest activity on Parsers VC dates from May 4, 2021.